期刊
ANNUAL REVIEW OF MEDICINE, VOL 65
卷 65, 期 -, 页码 157-170出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-med-092012-112344
关键词
antimetabolites; nucleotide synthesis; isocitrate dehydrogenase; glutamine
Therapeutic strategies designed to target cancer metabolism are an area of intense research. Antimetabolites, first used to treat patients in the early twentieth century, served as an early proof of concept for such therapies. We highlight strategies that attempt to improve on the antimetabolite approach as well as new metabolic drug targets. Some of these targets have the advantage of a strong genetic anchor to drive patient selection (isocitrate dehydrogenase 1/2, Enolase 2). Additional approaches described here derive from hypothesis-driven and systems biology efforts designed to exploit tumor cell metabolic dependencies (fatty acid oxidation, nicotinamide adenine dinucleotide synthesis, glutamine biology).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据